SPRYCEL DIGITAL HANDBOOK
It can be overwhelming to find out you have Ph+ CML. It is only natural to feel worried, fearful, and uncertain at this time. Find information that may help you as you learn more about your treatment.
WHY YOUR TREATMENT MILESTONES MATTER
What are “treatment milestones”?
In Ph+ CML, treatment results are called “milestones.” Your doctor uses treatment milestones to see how you're responding to your treatment plan.
HOW SPRYCEL WORKS
In Ph+ CML, an abnormal protein (BCR-ABL1) triggers the overproduction of damaged white blood cells. SPRYCEL® (dasatinib) works by helping to reduce the number of damaged white blood cells in your body.
SPRYCEL CLINICAL STUDY
More patients taking SPRYCEL achieved the study’s treatment milestones than those taking imatinib.
STUDY RESULTS AND SIDE EFFECTS
Below are study results and a list of side effects reported in adults in the SPRYCEL clinical study.
SPRYCEL is taken once daily, with or without food.
If you have Ph+ CML in chronic phase, the usual dose is 100 mg. Your healthcare provider may change your dose or temporarily stop treatment with SPRYCEL.
ADULT SAFETY INFORMATION
Medications like SPRYCEL can cause side effects. Read about them here.
Ask your doctor if the tips below are right for you.
SPRYCEL FINANCIAL SUPPORT RESOURCES
Bristol Myers Squibb is committed to helping patients gain access to their prescribed BMS medications.
ADDITIONAL Ph+ CML RESOURCES
Many organizations offer information and resources for those living with CML. See the list of organizations below.